Form 8-K - Current report:
SEC Accession No. 0001655759-25-000130
Filing Date
2025-07-09
Accepted
2025-07-09 07:01:54
Documents
12
Period of Report
2025-07-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K arvn-20250709.htm   iXBRL 8-K 23696
  Complete submission text file 0001655759-25-000130.txt   143575

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arvn-20250709.xsd EX-101.SCH 1782
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arvn-20250709_lab.xml EX-101.LAB 23451
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arvn-20250709_pre.xml EX-101.PRE 13581
14 EXTRACTED XBRL INSTANCE DOCUMENT arvn-20250709_htm.xml XML 2816
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

EIN.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38672 | Film No.: 251112255
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)